Seebri and Urticaria - a phase IV clinical study of FDA data

Summary:

Urticaria is reported as a side effect among people who take Seebri (glycopyrrolate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Xolair, and have Asthma.

The phase IV clinical study analyzes which people have Urticaria when taking Seebri. It is created by eHealthMe based on reports of 2,613 people who have side effects when taking Seebri from the FDA, and is updated regularly.

What is Seebri?

Seebri has active ingredients of glycopyrrolate. eHealthMe is studying from 2,618 Seebri users. Check the latest studies of Seebri.

What is Urticaria?

Urticaria (rash of round, red welts on the skin that itch intensely) is found to be associated with 2,612 drugs and 2,953 conditions by eHealthMe. Check the latest studies of Urticaria.



On Aug, 11, 2026

2,613 people reported to have side effects when taking Seebri.
Among them, 45 people (1.72%) have Urticaria.

Could Seebri cause Urticaria?

Among these 45 people:

How long have people been on Seebri when they have Urticaria? *

  • < 1 month: 66.67 %
  • 1 - 6 months: 16.67 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 16.67 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Urticaria when taking Seebri? *

  • female: 90.48 %
  • male: 9.52 %

What is the age of people who have Urticaria when taking Seebri? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 15.62 %
  • 40-49: 18.75 %
  • 50-59: 28.12 %
  • 60+: 37.5 %

What are other drugs people take besides Seebri? *

  1. Xolair: 38 people, 84.44%
  2. Ventolin: 25 people, 55.56%
  3. Alvesco: 24 people, 53.33%
  4. Advair Hfa: 24 people, 53.33%
  5. Synthroid: 15 people, 33.33%
  6. Singulair: 14 people, 31.11%
  7. Symbicort: 13 people, 28.89%
  8. Breo Ellipta: 12 people, 26.67%
  9. Nucala: 11 people, 24.44%
  10. Medrol: 10 people, 22.22%

What are other side effects people have besides Urticaria? *

  1. Cough: 39 people, 86.67%
  2. Asthma: 33 people, 73.33%
  3. Wheezing (a high-pitched whistling sound made while you breath): 29 people, 64.44%
  4. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 22 people, 48.89%
  5. Dyspnea (difficult or laboured breathing): 19 people, 42.22%
  6. Productive Cough: 19 people, 42.22%
  7. Dizziness: 17 people, 37.78%
  8. Middle Insomnia (difficulty returning to sleep after awakening either in the middle of the night): 17 people, 37.78%
  9. Fatigue (feeling of tiredness): 15 people, 33.33%
  10. Forced Expiratory Volume Decreased (decreased lung expired air volume): 15 people, 33.33%

What are the existing conditions these people have? *

  1. Asthma: 43 people, 95.56%
  2. Hypersensitivity: 3 people, 6.67%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 6.67%
  4. Pain: 2 people, 4.44%
  5. Multiple Allergies (allergy to multiple agents): 2 people, 4.44%
  6. High Blood Pressure: 2 people, 4.44%
  7. Sleep Disorder: 1 person, 2.22%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 2.22%
  9. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 1 person, 2.22%
  10. Lung Disorder (lung disease): 1 person, 2.22%

* Approximation only. Some reports may have incomplete information.

Do you take Seebri and have Urticaria?

- Check whether Urticaria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Seebri:

Urticaria treatments and more:

How severe was Urticaria and when was it recovered:

Expand to all the drugs that have ingredients of glycopyrrolate:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Seebri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urticaria:

Browse all the conditions that are associated with Urticaria:

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on glycopyrrolate (the active ingredients of Seebri) and Seebri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: